Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Immuron reports diarrhea no.1 health issue for Americans on vacation


News provided by

Immuron

Feb 12, 2020, 15:35 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Feb. 12, 2020 /PRNewswire/ -- Diarrhea remains the top health issue facing Americans traveling to high risk countries, affecting 30 to 70 per cent of travelers depending upon their destination, according to biopharmaceutical company Immuron Limited[1], [2].

Digestive distress and occasional diarrhea have the potential to significantly compromise a person's vacation or business trip. Around one-in-four travelers are forced to alter their plans due to diarrhea, and around five per cent are forced to seek medical care[3]. 

Continue Reading
Diarrhea remains the top health issue facing Americans traveling to high risk countries (PRNewsfoto/Immuron)
Diarrhea remains the top health issue facing Americans traveling to high risk countries (PRNewsfoto/Immuron)

Experiencing intestinal tract upsets such as occasional diarrhea, gas and bloating while traveling may not only prove embarrassing, but can also compromise travel experiences and reduce business productivity[3], [4]. Cancelling plans and paying for medical expenses while overseas can also prove costly.

Digestive upsets do not necessarily need to spoil the vacation of a lifetime, or an important business meeting. Travelan®, an extensively tested dietary supplement of clinically proven strength produced by Immuron, can be taken to support a healthy digestive system, whether at home in the USA or when traveling overseas.

Dr Bruce Kane, travel health specialist and owner of eight Passport Health travel medicine clinics in Michigan and Southwest, Florida, explains the high likelihood of developing occasional diarrhea at home or when traveling, and its resulting consequences:  

"Occasional diarrhea remains the most frequent health problem encountered by Americans, both at home and overseas. Diarrhea can be completely debilitating and, as many of my patients will attest, is not enjoyable for anyone who is unfortunate enough to experience it."

"Occasional diarrhea is typically caused by the consumption of food or water infected with bacteria, which attack the intestines, releasing diarrhea-causing toxins[1]. Bacterial pathogens, including E.coli and salmonella[1], [5] are the main culprit, and are thought to account for up to 80 to 90 per cent of occasional diarrhea cases[1]," said Dr Kane.  

"Other factors that can contribute to intestinal upset when traveling include the stress of travel and changes to our established routines including sleep, diet and exercise. At Passport Health, we recommend Travelan® to our patients to support a healthy digestive system and help maintain normal bowel habits while traveling."

"Digestive complaints including occasional diarrhea have the potential to ruin travel plans. Travelan® offers digestive tract protection and helps support the gut's immune defenses.[4] Diarrhea also has the potential to result in post-infectious Irritable Bowel Syndrome (IBS) and several post-infectious autoimmune diseases[6], [7], [8]. Furthermore, medical facilities in developing countries may not be up to US standards[9]."

Travelan's active ingredient, bovine colostrum enriched with anti-E. coli antibodies, has been shown to provide 90.9% protection against occasional diarrhea when two caplets are taken before meals, three times a day[10]. This makes Travelan® unique in its ability to promote digestive health.

Travelan® does not alter the microbiome of the gastrointestinal tract[4]. It does not negatively impact the essential microbiota of the gut and will not lead to antibiotic resistance, which is an increasing global concern[13].

Stacy Koski, Travel Nurse and Certified Holistic Nutrition Specialist from Sarasota, Florida, says most of her patients ask her how to maintain digestive health and avoid symptoms such as diarrhea.

"I recommend the 'non-salad diet' to my patients when they're on vacation, which involves eating foods that are thoroughly cooked, and only peeled fruits. However, this is not an exact science, and everyone is still at risk of developing intestinal upsets. I also recommend the use of the easy-to-take caplets of Travelan® to my patients before they head off to high risk destinations."

"I've heard many first-hand accounts from my patients about the benefits of taking Travelan before meals. Travelan® helps protect their digestive system while those around them have been struck down and confined to a hotel bathroom, ruining their vacation or work trip," said Stacy.

As well as being at risk at home in the States, the chance of developing occasional diarrhea increases markedly in countries with poor sanitation, such as South America[10], Central America[10], Mexico[11], The Caribbean[11], Asia[11], Africa[11], the Indian sub-continent[10] and the Middle East[11].

If food or drink is consumed in these areas that is contaminated with bacteria such as E. coli, the antibodies in Travelan® are designed to bind to the bacteria in the gastrointestinal tract, preventing them from attaching to the intestinal wall. This neutralizes the bacteria and its ability to cause diarrhea and other associated symptoms[4].

Liz Carlson, Travel blogger ("The Young Adventuress"), and Instagram influencer originally from Washington D.C., who travels the world for a living, comments on her use of Travelan®:

"Without a doubt, the worst I have ever felt while traveling abroad was when I was in Amed, Bali and was toilet-bound for days after eating a room service burger I had ordered. I genuinely thought I was going to die right there on the bathroom floor."

"I'd planned to go diving before heading off to my next destination in Indonesia and ended up having to cancel my plans. I was locked in my bathroom, feeling very ill and very sorry for myself. It took me three days to recover before I could continue on with my adventures," said Liz.

"Ever since that trip, I have used Travelan® whenever I plan on traveling in high-risk areas. It is important to me to eat locally and try new cuisines and Travelan® has helped to support my digestive system health on my adventures. I'd definitely recommend using Travelan®… it's better to be safe than sorry," said Liz.

Travelan® has been extensively tested and is supported by numerous studies. Travelan underwent Controlled Human Infection Model (CHIM) studies which were double-blinded placebo-controlled clinical trials in Europe and the US. The trials showed protection of up to 90.9 per cent[12] against the onset of occasional diarrhea. These studies have shown that people who received Travelan had significantly less discomfort and diarrhea than those who did not receive Travelan.

In addition, recent research studies conducted by the US Department of Defense, Walter Reed Army Institute of Research (WRAIR)[13], [14] demonstrate that the antibodies in Travelan® may be cross-reactive to an even broader range of bacteria than just E. coli. In 2018 WRAIR reported that the antibodies in Travelan® bound to 180 different isolates of bacteria including Campylobacter spp, ETEC and Shigella spp[13]. The pathogenic bacteria were retrieved from infected personnel deployed in Bhutan, Cambodia, Nepal and Thailand. Further studies also suggest that Travelan® may be cross-reactive to Vibrio cholera[14] and Salmonella[4], [15].

Travelan® is an essential item for anyone packing for their next trip. The product can be purchased online through Amazon or from Passport Health Clinics across America.

To learn more and for where to purchase Travelan, head to http://www.travelan.com.  

References

[1] Centers for Disease Control and Prevention, CDC Yellow Book 2020, Health Information for International Travel. 2019: Oxford University Press.

[2] Steffen, R., Epidemiology of travellers' diarrhea. J Travel Med, 2017. 24(suppl_1): p. S2-S5.

[3] Hill, D.R. and E.T. Ryan, Management of travellers' diarrhoea. BMJ, 2008. 337: p. a1746.

[4] Sears, K.T., et al., Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products. Clin Vaccine Immunol, 2017. 24(8).

[5] Khalil, I.A., et al., Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016. The Lancet. Infectious diseases, 2018. 18(11): p. 1229-1240.

[6] Thabane, M. and J.K. Marshall, Post-infectious irritable bowel syndrome. World J Gastroenterol, 2009. 15(29): p. 3591-6.

[7] Tribble, D.R., Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. Mil Med, 2017. 182(S2): p. 17-25.

[8] Connor, B.A. and M.S. Riddle, Post-infectious sequelae of travelers' diarrhea. J Travel Med, 2013. 20(5): p. 303-12.

[9] Collaborators, G.B.D.D.D., Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis, 2017. 17(9): p. 909-948.

[10] de Saussure, P.P., Management of the returning traveler with diarrhea. Therap Adv Gastroenterol, 2009. 2(6): p. 367-75.

[11] Better Health Channel. Traveller's diarrhoea.  December 2019]; Available from: https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/travellers-diarrhoea.

[12] Otto, W., et al., Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scandinavian journal of gastroenterology, 2011. 46(7-8): p. 862-868.

[13] US Department of Defense (WRAIR), US Defense Reports Broad Travelan Reactivity to 180 Pathogenic Bacteria including Camylobacter and Shigella. 2018, Immuron Limited.

[14] US Department of Defense (WRAIR), US Defense Reports Immuron's Travelan demonstrates broad reactivity to Vibrio cholera strains from Southeast Asia indicating broad potential for prevention of traveler's diarrhea. 2019, Immuron Limited.

[15] Ruamsap N, I.D., Imerbsin R, Kanellos J, Crawford J.M, Swierczewski B.E, Kaminski R.W, Passive immunotherapeutic of Hyperimmune Bovine Colostrum (HBC) to prevent Shigellosis in a Non-Human Primate model, in Vaccines for Enteric Diseases Conference. 2019: Switzerland.

SOURCE Immuron

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.